• ERS Genomics and Applied StemCell sign agreement on commercialization of CRISPR gene editing tools

    10 days ago - By News Medical

    ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with Applied StemCell, Inc., a leading provider of stem cell, animal model, antibody discovery services and reagents.
    Read more ...